Navigation Links
Olympus introduces the VisiGlide, a single-use guidewire
Date:10/27/2009

CENTER VALLEY, Pa., October 27, 2009 Olympus, a precision technology leader creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today announced the availability of VisiGlide1, its new single use guidewire developed with advanced technology from Terumo Corporation2 to facilitate ERCP procedures performed by gastroenterologists. Designed for use in endoscopic treatment of the bile and pancreatic ducts, the new 0.025 inch VisiGlide provides the same level of support and stiffness as a traditional 0.035 inch guidewire. Its enhanced design includes a super-elastic alloy and hydrophilic coatings to facilitate passage through strictures, an abnormal narrowing of a body passage, and makes selective insertion into the bile and pancreatic ducts easier.

By integrating Terumo's advanced materials processing technology with Olympus' endoscope and device combination technology, VisiGlide is expected to provide improved guidewire insertability and maneuverability in the bile and pancreatic ducts sites that are traditionally difficult to reach endoscopically. The core wire of VisiGlide is made of a super-elastic alloy with a thin fluorine coating on its shaft. Its supportive and kink-resistant design combined with its coatings enable the guidewire to pass smoothly through strictures while facilitating the exchange of ERCP devices. These advances in design are expected to make gastrointestinal procedures performed with the ERCP technique faster and easier.

VisiGlide provides visible markings to indicate various distances from the distal end in order to facilitate placement and confirmation of the guidewire's position in the endoscopic field of view during endoscopic treatment and when exchanging devices. This feature is expected to save X-ray radiation time. In addition, two radiopaque markers are incorporated to improve the visibility of the guidewire under fluoroscopy.

Market Introduction Background

In recent years, the occurrence of pancreaticobiliary diseases, such as drainage dysfunction of digestive fluids (bile and pancreatic juice) into the duodenum caused by biliary stricture and papillary stricture due to bile stones and malignant tumors, has been increasing. At the same, therapeutic modalities have been shifting from conventional surgery to endoscopic treatments that are less invasive for patients. The pancreatobiliary ducts are the most difficult site in the gastrointestinal tract to approach endoscopically, resulting in complex and protracted procedures in which multiple devices are variously advanced along a guidewire inserted into the papilla of Vater subsequent to observation of the exterior of the papilla (the opening of the bile and pancreatic ducts) with an endoscope that has been advanced to the duodenum. The VisiGlide is designed to reduce the demands this procedure imposes on doctors and staff and to reduce the time taken to perform it.


'/>"/>

Contact: Megan Longenderfer
Megan.Longenderfer@olympus.com
484-896-5579
GolinHarris International
Source:Eurekalert  

Related biology news :

1. Olympus broadens portfolio with new biliary metallic stent
2. Olympus advances technology for laparo-endoscopic single-site surgery
3. Advanced Analogic Technologies Introduces Lowest-Power Load Switch Available for Biometric Security Devices
4. Motorola Introduces Mobile Biometric Identification for Handheld Computers
5. GN Netcom Introduces Innovative Noise Blackout Technology
6. Silex Introduces SX-SDWAG 802.11a/b/g SDIO Radio Card for OEM Portable Device Applications
7. bioMETRX, Inc. Introduces New Products
8. M2SYS Introduces Revolutionary Biometric Artificial Intelligence Technology to Significantly Reduce Fingerprint Software False Reject Rates
9. ETH Zurich competence center ESC introduces energy strategy
10. Web-Hosted Attendance on Demand(R) Introduces Innovative Web Time Clock
11. Silex Introduces Worlds First Wireless USB Device Server With Streaming Video and Audio Data Transfer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Olympus introduces the VisiGlide, a single-use guidewire
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
Breaking Biology Technology: